Biotech Solutions & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-07-2024
- Paid Up Capital ₹ 5.08 M
as on 10-07-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 69.96%
(FY 2021)
- Profit 100.23%
(FY 2021)
- Ebitda 457.57%
(FY 2021)
- Net Worth 62.90%
(FY 2021)
- Total Assets 6.46%
(FY 2021)
About Biotech Solutions & Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.08 M, as per Ministry of Corporate Affairs (MCA) records.
Hasmukh Savani, Nilesh Kakadiya, and Piyushkumar Lakhani serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PLC234833
- Company No.
234833
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biotech Solutions & Pharmaceuticals Limited offer?
Biotech Solutions & Pharmaceuticals Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Methylcobalamin Tablets, Anti Infective Drugs & Medicines, Antibacterial Drugs, Vitamin Powder API, Calcium Ascorbate Powder, Antibiotic Tablets & Capsules, Azithromycin Tablets, Antifungal Injection, Tablet & Syrup, Fluconazole Tablet.
Who are the key members and board of directors at Biotech Solutions & Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Kakadiya  | Director | 23-Aug-2012 | Current |
| Hasmukh Savani | Director | 03-May-2019 | Current |
| Piyushkumar Lakhani | Director | 30-Jul-2016 | Current |
Financial Performance of Biotech Solutions & Pharmaceuticals.
Biotech Solutions & Pharmaceuticals Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 69.96% increase. The company also saw a substantial improvement in profitability, with a 100.23% increase in profit. The company's net worth Soared by an impressive increase of 62.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Solutions & Pharmaceuticals?
In 2021, Biotech Solutions & Pharmaceuticals had a promoter holding of 41.34% and a public holding of 58.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotech Solutions & Pharmaceuticals?
Unlock and access historical data on people associated with Biotech Solutions & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Solutions & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Solutions & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
